Oligo Medic has named Jerett Creed as CEO. Most recently Creed was in charge of launching Oligo Medic’s JointRep product throughout Latin America. Prior to that, Creed was founder and CEO of Cardigant Medical.
Creed began his career with Johnson and Johnson, ultimately spending more than a decade with the company finishing his tenure as director of business development.
Martin J. Madden has joined Novocure’s board of directors. Madden recently retired after a 30-year career in medical device innovation at Johnson & Johnson.
He most recently served as vice president, research and development DePuy-Synthes and vice president medical device r&d transformation.
LivaNova has hired Thad Huston as chief financial officer. Huston joins LivaNova after more than 25 years at Johnson & Johnson, having most recently served as group chief financial officer, medical devices.